Related Experiment Video
Updated: Jan 20, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
[Malignant hypertension: A bright future]
Romain Boulestreau1, Antoine Cremer2, Aurélien Lorthioir3
1Centre hospitalier de Pau, 4, boulevard Hauterive, 64000 Pau, France.
Abstract:
Malignant hypertension has not disappeared, it has been forgotten. Its incidence is increasing again. It considerably worsens the prognosis of young patients (35 to 55 years old on average). There might be susceptibility factors, several hypotheses are under study. New diagnostic criteria and therapeutic options have been proposed and will have to be validated. Faced with these important challenges for patients, the first prospective multicentric register on this pathology will be set up in France in September 2019.
Related Concept Videos
08:32Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Future Value
Understanding future value offers several benefits. For example, it helps in making informed investment decisions. By projecting investment growth, individuals can compare financial products...
Future Value and Compounding
05:24Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Hypertension I: Introduction
